Literature DB >> 12460470

Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.

Kei-ji Sugimoto1, Norihiko Kawamata, Sakura Sakajiri, Kazuo Oshimi.   

Abstract

Natural killer (NK) cell neoplasms are rare diseases. Frequent abnormalities of the tumor suppressor genes Rb, p53, p15INK4B, p16INK4A and p14ARF have been reported. However, no oncogenes associated with tumorigenesis of NK cell neoplasms have been reported so far. We analyzed the status of oncogenes including N-ras, K-ras, H-ras, c-myc, N-myc and mdm2 by Southern blot, PCR-SSCP, western blot analysis and immunohistochemical staining. We analyzed four cell lines derived from NK cell neoplasms and 31 clinical samples with five subclasses of NK cell neoplasms. We found no point mutations of the ras family genes. We detected no mutations in the c-myc and N-myc genes. No overexpression of c-Myc protein was detected by western blot analysis. Although we found neither amplification nor rearrangement of the mdm2 gene, we found high expression of MDM2 protein in some cases by western blot analysis. Immunohistochemical staining confirmed the overexpression of MDM2 protein. We found 14 cases with overexpression of MDM2 protein out of 15 cases (93%) with four subclasses of NK cell neoplasms except chronic NK lymphocytosis. Our previous and these results suggested that the expression level of MDM2 protein is independent of the status of the p14ARF, p53, Rb genes. MDM2 protein might independently contribute to carcinogenesis of NK cell neoplasms. Although the number of the cases we analyzed was not large, alterations of ras and myc family genes may rarely contribute to tumorigenesis in NK cell neoplasms. In contrast, overexpression of MDM2 might be associated with tumorigenesis of NK cell neoplasms, especially aggressive subclasses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460470      PMCID: PMC5926889          DOI: 10.1111/j.1349-7006.2002.tb01234.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  40 in total

1.  Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association.

Authors:  A C Chan; J W Ho; A K Chiang; G Srivastava
Journal:  Histopathology       Date:  1999-01       Impact factor: 5.087

Review 2.  Overexpression of the MDM2 oncogene in leukemia and lymphoma.

Authors:  T Watanabe; A Ichikawa; H Saito; T Hotta
Journal:  Leuk Lymphoma       Date:  1996-05

Review 3.  Lymphoproliferative disorders of natural killer cells.

Authors:  K Oshimi
Journal:  Int J Hematol       Date:  1996-06       Impact factor: 2.490

4.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.

Authors:  L L Siu; K F Wong; J K Chan; Y L Kwong
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.

Authors:  A K Chiang; A C Chan; G Srivastava; F C Ho
Journal:  Int J Cancer       Date:  1997-11-04       Impact factor: 7.396

Review 6.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

7.  Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.

Authors:  J A DiGiuseppe; D C Louie; J E Williams; D T Miller; C A Griffin; R B Mann; M J Borowitz
Journal:  Am J Surg Pathol       Date:  1997-10       Impact factor: 6.394

8.  Frequent mutations of Fas gene in nasal NK/T cell lymphoma.

Authors:  Tetsuya Takakuwa; Zhiming Dong; Shinichi Nakatsuka; Shizuo Kojya; Yasuaki Harabuchi; Woo-Ick Yang; Shigekazu Nagata; Katsuyuki Aozasa
Journal:  Oncogene       Date:  2002-07-11       Impact factor: 9.867

9.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

Authors:  M J Robertson; K J Cochran; C Cameron; J M Le; R Tantravahi; J Ritz
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

Review 10.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

View more
  6 in total

Review 1.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 2.  Leukemia and lymphoma of natural killer lineage cells.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 3.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

4.  Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.

Authors:  Jeong A Park; Kyung Ran Jun; So Hyun Nam; Thad T Ghim
Journal:  Int J Hematol       Date:  2013-04-04       Impact factor: 2.490

5.  RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.

Authors:  V Selvarajan; M Osato; G S S Nah; J Yan; T-H Chung; D C-C Voon; Y Ito; M F Ham; M Salto-Tellez; N Shimizu; S-N Choo; S Fan; W-J Chng; S-B Ng
Journal:  Leukemia       Date:  2017-01-25       Impact factor: 11.528

6.  Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma.

Authors:  Shanshan Li; Tingzhi Liu; Hailing Liu; Xiaohui Zhai; Taiyuan Cao; Hongen Yu; Wanjia Hong; Xiaoru Lin; Ming Li; Yan Huang; Jian Xiao
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.